The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Oh well wait for the icing on the cake. Remember to vote tweet.
Does their first responder unit have a resuscitation branch, anymore drivel today and some holders may need it.
i guess James Wakefield used his lunch money today to purchase 7k shares .
Sorry to ask but quick question: Are directors allowed to buy or sell shares so close to price sensitive updates? I didn't think they would be but not sure...
Piscean, you won't get shot down. It would surprise none of us if that happened here. There is zero trust now.
Finally a good post by positive investor 100 please stick to your word this time!
#brokenbetpromises
At the risk of being shot down here I'm getting a bad feeling of deja vu. Shortly before Sirius minerals was sold for peanuts to AAL the CEO Chris Fraser purchased £10, 000 worth of shares, then rode off into the Australian sunset with his millions stuffed in his pocket
You're an idiot. Green bin. Bye.
PL100 i will share with those of intelligence… which clearly you have none (imo deliberately)
Why rest ? You et all dont!
I feel sorry for anyone paid more then £10 not that long ago
When I said this morning that the chairman needed to stick his hand in his pocket or do one, I didn't expect him to literally do that and use his lunch money.
That purchase is a f@cking insult.
The value of microgen and lab 21..... Wonder what will happen to framework contract.... No value on microgen in figures.... Someone will purchase at a price add to kitty.... Pathflow transferred as other tests... Rush rush rush
hamsters - it may be but if we lose the dispute the company's name is in the mud, which is irrelevant as it'll be all but wound up. 3. True but before covid we didn't have (on paper) £100M. We clearly have no idea what to do with it, isn't that a little worrying?
PI100, fair play.
1 & 4 cannot argue with those statements!
2 I think NCYTs reputation for its core work is strong.
3 compared to covid times, yes, but if covid had not happened sales might have be deemed good? (who knows)
Go troll somewhere else.
£100M if we don't lose the dispute. Why is everyone here so adamant we won't?
Business isn't dead? It's become bloated due to the covid lottery win but non covid revenue is £7M per annum (sorry, just re-read the RNS and my earlier post of £6M was wrong). £7M income. We are spending £10M on R&D for ****s sake. R&D that may amount to absolutely zero sales. Now, tell me again there is no cash burn. We have a board on hundreds of thousands per annum who are after a 10% increase whilst knowing the business is on its knees and getting worse. So, 1. the market hates us, 2. our reputation is currently diminished due to the dispute, 3. we are selling **** all, 4. the Directors put out nothing that is positive in an RNS.
Oh yippee, an offer. Someone may take us over at, what, £1.30 a share? Thrilling.
PI100, with 100m in the bank and tiny cash burn, I do not think the business is dead, it is evolving post covid and probably has a good reputation regarding R&D and the speed of reacting to world needs, like now monkeypox.
The possible DHSC resolution is also a positive possibility. I would not be surprised if an offer comes, and that something is going on behind the scenes, but compared to other covid stocks, NCYT is the most marketable and healthy imv, just the SP does not show it.
Give it a rest, Val. The SP is £1.11 for ****s sake. Remove covid and our revenue is £6M/annum. £6M PER ANNUM. I will do the maths later when I have the time but from memory covid income had decreased by circa 65-67% in Q1 and it's now mid 70's. It'll be gone by year end. What is it you are positive about, please do share?
Any new investors.... Over 500 shares is a good idea if just under
There you go again, mr positive investor… #saysitall
Agree (for the few that think im sad/mad/whatever) its not pretty or perfect at present… but!
One decent piece of news (inc hostile takeover) could push it to a 12 month high? Meaning many could salvage something?
Of course many who helped trash Co and SP, will no doubt earn a fortune… but then hopefully move on?
dyor all imo
Guess is 25%. This second RNS will have zero impact, the first one is more important and has confirmed that the business is dead.
I guess £10k is better than nothing and at least the 5min chart looks more healthy, guess on close? 15% down?